Key Takeaways: Retatrutide (Triple-G Peptide) is a next-generation, triple-hormone GLP-1/GIP/glucagon medication currently in clinical trials, showing record-breaking fat-loss potential
Scale weight loss typically slows after month 6, but body composition improvements often continue through months 612 sometimes more dramatically than the first 16 weeks
GLP-1 medications can produce rapid weight reduction that outpaces the skins ability to adjust, creating more pronounced laxity
Prescription Anti-Nausea Medications When over-the-counter and natural remedies arent enough, prescription medications exist for a reason
In recent years, GLP-1 (Glucagon-like Peptide 1) receptor agonistsdrugs initially developed to treat type 2 diabeteshave gained attention as a potential medication in combating obesity
Son anlogos de la incretina GLP-1 utilizados en diabetes tipo 2 y, en algunos casos, en control de peso